Browse diseases

…population demographics within this cohort and for all stage IV lung cancer diagnoses between 2022 and 2024.Results Of 410 patients diagnos…

…nal avoidance plans.Results 19F MRI scans were acquired from 12 NSCLC patients and RLCI maps created. 6 participants have had standar…

…ic changes in the tumor microenvironment (TME) in patients with non-small cell lung cancer (NSCLC) and acquired resistance to epidermal growth factor rece…

…ze treatment selection for patients with early-stage inoperable NSCLC. If validated, it could serve as a foundation for a treatment-f…

…roduction. Clinical correlations were analyzed in patients with NSCLC treated with EGFR-TKIs.Results Osimertinib triggered NLRP3 infl…

…, we characterize the effect of CH on ICI objective response in non-small cell lung cancer (NSCLC).Methods We performed baseline blood-derived whole-exome…

…s was a high-risk factor for cancer-related death in metastatic NSCLC.Conclusions The mutational burden, PD-L1 expression and IC infi…

…) therapy remains a major challenge for cancer immunotherapy in non-small cell lung cancer (NSCLC). Gut microbial metabolites can influence immunotherapy …

… instance, A*02:01-specific LOH was linked to worse survival in CRC (HR 0.5355, 95% CI 0.2991 to 0.9589, p=0.0094) but showed a tre…

… checkpoint inhibitors (ICI) improved survival of patients with non-small cell lung cancer (NSCLC), yet many patients do not respond to treatment. The ide…

… showed a higher Gini index. While in the operated patient with NSCLC cohort, TCR clonality was not prognostic, in an immune checkpoi…

…tion of trial results and, most importantly, failure to improve cancer outcomes where they are needed most.…